Psychiatric Pharmacotherapy Update
In-person and via live broadcast on October 26-27, 2023
The goal of the Psychiatric Pharmacotherapy Update is to improve the quality of care delivered to people with mental health disorders by providing timely and clinically relevant information for the practicing clinician.
The Psychiatric Pharmacotherapy Update offers live in-person programming in Austin, Texas on Thursday, October 26 and Friday, October 27. Participants are encouraged to join us in person but those unable to make it to Austin can attend via our live broadcast.
Programming will be recorded and available on-demand after the event along with supplemental resources and downloadable presentation slides for CE students to access and complete to meet their practice needs.
–Save the date: |
October 26-27, 2023
6505 North IH-35
Austin, TX 78752
(512) 454-3737
(800) 347-0330
Online broadcast is also available.
Who should attend?– |
Pharmacists, psychiatrists, physicians, nurses, physician assistants, psychologists and social workers* who specialize in or have an interest in neuropsychiatric disorders and wish to enhance their awareness and knowledge of the most recent advances impacting contemporary practice.
*Social workers, please see the agenda to identify which sessions (*) have been designated as information that will meet your specific educational needs, and offer social work-specific continuing education credit. Please feel free to register for the entire conference if you wish to participate in the non-accredited sessions for your own professional development.
Conference Takeaways |
Conference speakers focus on the practical application of neuroscience principles and evidence-based approaches for treating severe and persistent major psychiatric and neurologic disorders, including depression, schizophrenia, bipolar disorder and dementia.
Participants are provided with treatment advances in the psychiatric pharmacotherapy of children, traumatic brain injury and substance abuse, and an update on new psychotherapeutic uses of existing and new psychotropic agents that will impact your practice in the next year.
